Notable Analyst Rating Changes for 11/30: X, DE, AFL, AEO Upgraded; BIDU, SWY, BKC, SVU Downgraded
UPGRADES:
Goldman Added US Steel (NYSE: X) to their Conviction Buy List with a new 6-month price target of $54. Goldman also upgraded the Steel sector from Neutral to Attractive. Click Here for more color.
JPMorgan upgrades Deere (NYSE: DE) from Underweight to Neutral, also raising its price target from $47 to $52. Wells Fargo also upgraded Deere & Co. from Market Perform to Outperform. Valuation range increased from $48-50 to $65-68. For more color from Wells, Click Here.
Credit Suisse is out with an interestingly timed upgrade on Aflac (NYSE: AFL) raising their rating to Outperform from Neutral with a $60 price target (prev. $52). Click Here for more color.
Lazard Capital upgrades American Eagle Outfitters (NYSE: AEO) from Hold to Buy.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Sanford C. Bernstein downgrades Baidu (NASDAQ: BIDU) from Outperform to Market Perform but raises their price target from $420 to $460.
Morgan Stanley has effectively upgraded shares of Safeway (NYSE: SWY) from Underweight to Equalweight.
Wedbush downgrades Burger King (NYSE: BKC) from Neutral to Underperform. Price target lowered to $17 from $19.
Morgan Stanley downgrades SUPERVALU (NYSE: SVU) from Equalweight to Underweight, and set a price target of $13.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Credit Suisse restarts coverage on MEMC Electronic Materials (NYSE: WFR) with a Neutral rating.
Goldman Sachs resumes coverage on Autodesk (NASDAQ: ADSK) with a Neutral rating and 12-month price target of $27.
Citi, Wells Fargo, and Natixis Bleichroeder initiated coverage on AGA Medical (NASDAQ: AGAM) with a Buy, Market Perform, and Buy, respectively. The firms saw price targets of $19, $13 - $14, and $20, respectively. For more color from Wells, Click Here. For more from Natixis, Click Here.
Wells Fargo initiates coverage on AGA Medical Holdings (Nasdaq: AGAM) with a Market Perform rating. Valuation range is $13-14. Natixis Bleichroeder initiates coverage on AGA Medical (Nasdaq: AGAM) with a Buy. Price target $20.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
Related Entities
- Goldman Sachs Conviction Buy List
- Credit Suisse
- JPMorgan
- Citi
- Morgan Stanley
- Sanford C. Bernstein
- Lazard
- Natixis Bleichroeder
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
